Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
Titel:
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study
Auteur:
Briasoulis, E. Fountzilas, G. Bamias, A. Dimopoulos, M. A. Xiros, N. Aravantinos, G. Samantas, E. Kalofonos, H. Makatsoris, T. Mylonakis, N. Papakostas, P. Skarlos, D. Varthalitis, I. Pavlidis, N.